Status:
COMPLETED
Benefits Study of Respiratory-gated PET Acquisition in Lung Disease
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Lung Cancer
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fluorodeoxyglucose (FDG) positron emission tomography (PET) is now widely used for cancer imaging purpose, notably for preoperative work-up. It aims at visualizing organs metabolism. In case of cancer...
Eligibility Criteria
Inclusion
- patient has one or more lung lesion(s) less than 35 mm visible on a CT image
- age : over 18 years
- patients gave their written informed consent
Exclusion
- pregnancy
- patient has at least one lesion more than 35 mm in its great axis
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT01812031
Start Date
August 1 2009
End Date
February 1 2015
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, Picardie, France, 80054